Residual Risk Beyond Statins

Residual Risk Beyond Statins is organized by European Association of Preventive Cardiology (EAPC), European Society of Cardiology (ESC) and will be held on Mar 22, 2023.

Learning objectives:
After watching this webinar, participants will:
• appreciate the current status of LDL-C goal attainment with statins; 
• recognize the residual clinical risk associated with suboptimal LDL-C control; 
• understand the indications of novel LDL-C-lowering medications beyond statins;
• recognise the residual lipid-related risk beyond LDL-C [lipoprotein(a), triglycerides]; and 
• be aware of novel medications to address this risk.

Needs assessment and expected educational outcome
To understand what statins can and cannot do to reduce the dangers of low-density lipoproteins.

Additional details will be posted as soon as information is available.